Xiao Ming Zhu
Corporate Officer/Principal chez MicroPort Cardiac Rhythm Management International Ltd.
Profil
Xiao Ming Zhu is currently the General Manager-China Region at MicroPort Cardiac Rhythm Management International Ltd.
Prior to this, he worked as the Marketing Director at Medtronic (Shanghai) Management Co. Ltd.
from 2013 to 2014, and as the Head-Senior Marketing Manager at Edwards (Shanghai) Medical Products Co., Ltd.
from 2011 to 2013.
Zhu received his undergraduate degree from Shanghai Jiao Tong University School of Medicine in 1992.
Postes actifs de Xiao Ming Zhu
| Sociétés | Poste | Début |
|---|---|---|
MicroPort Cardiac Rhythm Management International Ltd.
 MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01/09/2014 |
Anciens postes connus de Xiao Ming Zhu
| Sociétés | Poste | Fin |
|---|---|---|
Medtronic (Shanghai) Management Co. Ltd.
 Medtronic (Shanghai) Management Co. Ltd. Medical DistributorsDistribution Services Part of Medtronic Plc, Medtronic (Shanghai) Management Co. Ltd. provides services and support for medical equipment, including a comprehensive portfolio of ENT office-based sinus surgery solutions and spinal fusion and artificial disc therapies. The company is based in Shanghai, China. The Chinese company offers bone graft options and minimally invasive spinal surgery options for patients. Recently, their MiniMed™ 780G system has been FDA approved, which allows for real-time insulin adjustments and corrections. | Sales & Marketing | 01/08/2014 |
| Edwards (Shanghai) Medical Products Co., Ltd. | Corporate Officer/Principal | 01/09/2013 |
Formation de Xiao Ming Zhu
| Shanghai Jiao Tong University School of Medicine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Medtronic (Shanghai) Management Co. Ltd.
Medtronic (Shanghai) Management Co. Ltd. Medical DistributorsDistribution Services Part of Medtronic Plc, Medtronic (Shanghai) Management Co. Ltd. provides services and support for medical equipment, including a comprehensive portfolio of ENT office-based sinus surgery solutions and spinal fusion and artificial disc therapies. The company is based in Shanghai, China. The Chinese company offers bone graft options and minimally invasive spinal surgery options for patients. Recently, their MiniMed™ 780G system has been FDA approved, which allows for real-time insulin adjustments and corrections. | Distribution Services |
| Edwards (Shanghai) Medical Products Co., Ltd. | |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |
